The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Hoth Therapeutics, Inc(NASDAQ:HOTH) 
Hoth Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for dermatological disorders. The company focuses on therapies for patients suffering from indications, including eczema, chronic wounds, psoriasis, asthma, and acne. Its pipeline portfolio includes HT-001, a topic...
Website: http://www.hoththerapeutics.com
Founded: 2017
Full Time Employees: 2
Sector: Healthcare
Industry: Biotechnology
Hoth Therapeutics Days Payable Outstanding ttm (DPO)
Hoth Therapeutics Op Cashflow Per Share ttm
Hoth Therapeutics Free Cashflow Per Share ttm
Hoth Therapeutics Cash Per Share ttm
Hoth Therapeutics (GAAP) P/E ratio ttm
Hoth Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.